On this episode, we review the pathophysiology, signs/symptoms, and treatment of hypothyroidism. We compare and contrast the pharmacotherapy options and the evidence that supports current guideline recommendations. We then move into the management of myxedema coma. We close by summarizing the various drugs that have become FDA approved over the last month.